Dexcom's Trading Volume Soars to $388 Million, Ranked 214th Despite Stock Price Decline

On March 27, 2025, Dexcom's trading volume reached $388 million, marking a 64.48% increase from the previous day, placing it at the 214th position in the day's stock market rankings. However, Dexcom's stock price has been on a downward trend, falling 3.69% and marking its third consecutive day of decline, with a total decrease of 7.77% over the past three days.

Dexcom received a warning letter from the FDA, highlighting several issues with the manufacturing of its popular G6 and G7 sensors. The company's response to these concerns was deemed inadequate, raising significant worries about the approval of the 15-day G7 sensor.

Dexcom made a substantial design change to a component used in its sensors without properly validating the change, according to the FDA's warning letter. This revelation has added to the concerns surrounding the company's sensor technology and its regulatory compliance.

Motley Fool Wealth Management LLC reduced its stake in DexCom, Inc. by 12.0% during the fourth quarter, indicating a shift in investor sentiment towards the company.